• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ATP 酶抑制剂因子 1(IF)在癌细胞适应缺氧和乏氧中的作用。

The role of the ATPase inhibitor factor 1 (IF) in cancer cells adaptation to hypoxia and anoxia.

机构信息

Department of Biomedical and Neuromotor Sciences, Laboratory of Biochemistry and Mitochondrial Pathophysiology, University of Bologna, via Irnerio, 48, 40126 Bologna, Italy.

Department of Biomedical and Neuromotor Sciences, Laboratory of Biochemistry and Mitochondrial Pathophysiology, University of Bologna, via Irnerio, 48, 40126 Bologna, Italy.

出版信息

Biochim Biophys Acta Bioenerg. 2018 Feb;1859(2):99-109. doi: 10.1016/j.bbabio.2017.10.007. Epub 2017 Oct 31.

DOI:10.1016/j.bbabio.2017.10.007
PMID:29097244
Abstract

The physiological role of the mitochondrial ATP synthase complex is to generate ATP through oxidative phosphorylation. Indeed, the enzyme can reverse its activity and hydrolyze ATP under ischemic conditions, as shown in isolated mitochondria and in mammalian heart and liver. However, what occurs when cancer cells experience hypoxia or anoxia has not been well explored. In the present study, we investigated the bioenergetics of cancer cells under hypoxic/anoxic conditions with particular emphasis on ATP synthase, and the conditions driving it to work in reverse. In this context, we further examined the role exerted by its endogenous inhibitor factor, IF, that it is overexpressed in cancer cells. Metabolic and bioenergetic analysis of cancer cells exposed to severe hypoxia (down to 0.1% O) unexpectedly showed that Δψ is preserved independently of the presence of IF and that ATP synthase still phosphorylates ADP though at a much lower rate than in normoxia. However, when we induced an anoxia-mimicking condition by collapsing Δμ with the FCCP uncoupler, the IF-silenced clones only reversed the ATP synthase activity hydrolyzing ATP in order to reconstitute the electrochemical proton gradient. Notably, in cancer cells IF overexpression fully prevents ATP synthase hydrolytic activity activation under uncoupling conditions. Therefore, our results suggest that IF overexpression promotes cancer cells survival under temporary anoxic conditions by preserving cellular ATP despite mitochondria dysfunction.

摘要

线粒体 ATP 合酶复合物的生理作用是通过氧化磷酸化生成 ATP。事实上,该酶可以在缺血条件下逆转其活性并水解 ATP,这在分离的线粒体以及哺乳动物心脏和肝脏中都有显示。然而,当癌细胞经历缺氧或缺氧时会发生什么,尚未得到很好的探索。在本研究中,我们研究了缺氧/缺氧条件下癌细胞的生物能量学,特别强调了 ATP 合酶及其驱动其反向工作的条件。在这种情况下,我们进一步研究了其内源性抑制剂因子 IF 所发挥的作用,IF 在癌细胞中过度表达。暴露于严重缺氧(低至 0.1% O)下的癌细胞的代谢和生物能量学分析出人意料地表明,Δψ 独立于 IF 的存在而得以保留,并且 ATP 合酶仍可通过 ADP 磷酸化,但磷酸化速率远低于正常氧合时的速率。然而,当我们用 FCCP 解偶联剂使 Δμ崩溃以诱导类似缺氧的条件时,沉默 IF 的克隆仅逆转 ATP 合酶活性以水解 ATP,从而重新构成电化学质子梯度。值得注意的是,IF 过表达完全阻止了在解偶联条件下 ATP 合酶水解活性的激活。因此,我们的结果表明,IF 过表达通过在粒体功能障碍的情况下仍保持细胞内 ATP,促进了癌细胞在暂时缺氧条件下的存活。

相似文献

1
The role of the ATPase inhibitor factor 1 (IF) in cancer cells adaptation to hypoxia and anoxia.ATP 酶抑制剂因子 1(IF)在癌细胞适应缺氧和乏氧中的作用。
Biochim Biophys Acta Bioenerg. 2018 Feb;1859(2):99-109. doi: 10.1016/j.bbabio.2017.10.007. Epub 2017 Oct 31.
2
The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival.三磷酸腺苷酶抑制因子1(IF1):能量代谢和细胞存活的主要调节因子。
Biochim Biophys Acta. 2016 Aug;1857(8):1167-1182. doi: 10.1016/j.bbabio.2016.02.004. Epub 2016 Feb 12.
3
The F1Fo-ATPase inhibitor, IF1, is a critical regulator of energy metabolism in cancer cells.F1Fo - ATP酶抑制剂IF1是癌细胞能量代谢的关键调节因子。
Biochem Soc Trans. 2021 Apr 30;49(2):815-827. doi: 10.1042/BST20200742.
4
Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype.人肿瘤中线粒体 H+-ATP 合酶的 ATP 酶抑制因子 1(IF1)上调介导癌细胞向瓦博格表型的代谢重编程。
J Biol Chem. 2010 Aug 13;285(33):25308-13. doi: 10.1074/jbc.M110.146480. Epub 2010 Jun 9.
5
The Pro-Oncogenic Protein IF Promotes Proliferation of Anoxic Cancer Cells during Re-Oxygenation.促癌蛋白 IF 在再复氧时促进缺氧癌细胞的增殖。
Int J Mol Sci. 2023 Sep 27;24(19):14624. doi: 10.3390/ijms241914624.
6
PKA Phosphorylates the ATPase Inhibitory Factor 1 and Inactivates Its Capacity to Bind and Inhibit the Mitochondrial H(+)-ATP Synthase.蛋白激酶A使ATP酶抑制因子1磷酸化,并使其结合和抑制线粒体H(+) -ATP合酶的能力失活。
Cell Rep. 2015 Sep 29;12(12):2143-55. doi: 10.1016/j.celrep.2015.08.052. Epub 2015 Sep 17.
7
Regulation of the H-ATP synthase by IF1: a role in mitohormesis.IF1对H-ATP合酶的调节:在线粒体应激反应中的作用
Cell Mol Life Sci. 2017 Jun;74(12):2151-2166. doi: 10.1007/s00018-017-2462-8. Epub 2017 Feb 6.
8
Mitochondrial bioenergetic profile and responses to metabolic inhibition in human hepatocarcinoma cell lines with distinct differentiation characteristics.线粒体生物能量特征及对具有不同分化特征的人肝癌细胞系代谢抑制的反应。
J Bioenerg Biomembr. 2011 Oct;43(5):493-505. doi: 10.1007/s10863-011-9380-5. Epub 2011 Sep 1.
9
Investigation of the role and mechanism of IF1 and STF1 proteins, twin inhibitory peptides which interact with the yeast mitochondrial ATP synthase.与酵母线粒体ATP合酶相互作用的双抑制肽IF1和STF1蛋白的作用及机制研究
Biochemistry. 2003 Jun 24;42(24):7626-36. doi: 10.1021/bi034394t.
10
Glucose-modulated mitochondria adaptation in tumor cells: a focus on ATP synthase and inhibitor Factor 1.肿瘤细胞中葡萄糖调节的线粒体适应性:聚焦于ATP合酶和抑制因子1
Int J Mol Sci. 2012;13(2):1933-1950. doi: 10.3390/ijms13021933. Epub 2012 Feb 10.

引用本文的文献

1
ATP Supply from Cytosol to Mitochondria Is an Additional Role of Aerobic Glycolysis to Prevent Programmed Cell Death by Maintenance of Mitochondrial Membrane Potential.从胞质溶胶到线粒体的ATP供应是有氧糖酵解的另一个作用,通过维持线粒体膜电位来防止程序性细胞死亡。
Metabolites. 2025 Jul 7;15(7):461. doi: 10.3390/metabo15070461.
2
An alternative mechanism by which If1 prevents ATP hydrolysis by the ATP synthase subcomplex in S. cerevisiae.在酿酒酵母中,If1阻止ATP合酶亚复合体水解ATP的另一种机制。
EMBO Rep. 2025 Jun 9. doi: 10.1038/s44319-025-00430-8.
3
Modification in Structures of Active Compounds in Anticancer Mitochondria-Targeted Therapy.
抗癌线粒体靶向治疗中活性化合物结构的修饰。
Int J Mol Sci. 2025 Feb 6;26(3):1376. doi: 10.3390/ijms26031376.
4
Peptides Targeting the IF1-ATP Synthase Complex Modulate the Permeability Transition Pore in Cancer HeLa Cells.靶向 IF1-ATP 合酶复合物的肽调节癌细胞 HeLa 中的通透性转换孔。
Int J Mol Sci. 2024 Apr 25;25(9):4655. doi: 10.3390/ijms25094655.
5
Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies.髓系来源的抑制性细胞线粒体功能状态决定血液系统恶性肿瘤的化疗疗效。
Nat Commun. 2024 Mar 30;15(1):2803. doi: 10.1038/s41467-024-47096-9.
6
Variants in Human ATP Synthase Mitochondrial Genes: Biochemical Dysfunctions, Associated Diseases, and Therapies.人类 ATP 合成酶线粒体基因变异:生化功能障碍、相关疾病和治疗方法。
Int J Mol Sci. 2024 Feb 13;25(4):2239. doi: 10.3390/ijms25042239.
7
Conformational ensemble of yeast ATP synthase at low pH reveals unique intermediates and plasticity in F-F coupling.酵母 ATP 合酶在低 pH 下的构象整体揭示了 F-F 偶联中的独特中间体和可塑性。
Nat Struct Mol Biol. 2024 Apr;31(4):657-666. doi: 10.1038/s41594-024-01219-4. Epub 2024 Feb 5.
8
The Warburg Effect Explained: Integration of Enhanced Glycolysis with Heterogeneous Mitochondria to Promote Cancer Cell Proliferation.沃伯格效应解析:增强的糖酵解与异质性线粒体的整合促进癌细胞增殖。
Int J Mol Sci. 2023 Oct 31;24(21):15787. doi: 10.3390/ijms242115787.
9
The Pro-Oncogenic Protein IF Promotes Proliferation of Anoxic Cancer Cells during Re-Oxygenation.促癌蛋白 IF 在再复氧时促进缺氧癌细胞的增殖。
Int J Mol Sci. 2023 Sep 27;24(19):14624. doi: 10.3390/ijms241914624.
10
The mitochondrial inhibitor IF1 binds to the ATP synthase OSCP subunit and protects cancer cells from apoptosis.线粒体抑制剂 IF1 与 ATP 合酶 OSCP 亚基结合,保护癌细胞免于凋亡。
Cell Death Dis. 2023 Jan 23;14(1):54. doi: 10.1038/s41419-023-05572-y.